In conclusion, TRPM3 dysfunction in post-COVID-19 condition and ME/CFS participants suggests impairment in ion mobilization and consequently results in Ca2+ signaling and cell homeostasis disturbance in both diseases. Here, TRPM3 is linked to COVID-19.